跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIPERACILINA/TAZOBACTAM QILU 4 G/0,5 G POLVO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PIPERACILINA/TAZOBACTAM QILU 4 G/0,5 G POLVO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
PIPERACILINA/TAZOBACTAM QILU 4 G/0,5 G POLVO PARA SOLUCION PARA PERFUSION EFG
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 24, 2023
Approval ID
bcd6dabdb0d70dd5
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
bcd6dabdb0d70dd5
Drug Cima Aemps Name
PIPERACILINA/TAZOBACTAM QILU 4 G/0,5 G POLVO PARA SOLUCION PARA PERFUSION EFG
Register Number
88989
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Sun Pharma Laboratorios S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2023-07-24
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
4 g/ 0,5 g
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
PIPERACILINA SODICA
4,16 g
TAZOBACTAM SODICO
0,53 g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 24, 2023
Approval ID
bcd6dabdb0d70dd5
Type
Standard
Back to CIMA-AEMPS Approvals